HPV is a virus, usually transmitted sexually, which can cause cervical cancer in a small percentage of those women genital infected.<unk>  is a preventative HPV vaccine, not therapeutic. HPV immunity is type-specific, so a successful series of<unk>  shots will not block infection from cervical cancer-causing HPV types other than HPV types 16 and 18 and some related types, so experts continue to recommend routine cervical Pap smears even for women who have been vaccinated. Vaccination alone, without continued screening, would prevent fewer cervical cancers than regular screening alone.<unk>  is indicated for the prevention of the following diseases caused by oncogenic HPV types 16 and 18: cervical cancer, cervical intraepithelial neoplasia (CIN) grade 2 or worse and adenocarcinoma in situ, and CIN grade 1. In the United States,<unk>  is approved for use in females 10 through 25 years of age while in some other countries the age limit is at least 45. ,<unk>  was shown to be effective 7.3 years after vaccination. Administration Immunization with<unk>  consists of 3 doses of 0.5-mL each, by intramuscular injection according to the following schedule: 0, 1, and 6 months. The preferred site of administration is the deltoid region of the upper arm.<unk>  is available in 0.5-mL single-dose vials and prefilled TIP-LOK syringes. Limitations of effectiveness<unk>  does not provide protection against disease due to all HPV types, nor against disease if a woman has previously been exposed through sexual activity and protection may not be obtained by all recipients. It is therefore recommended that women continue to adhere to cervical cancer screening procedures.
Cervarix
Aneugen
Cloforex
Lipotuck
Vinegar
Almanac
Tolibut
Alloplant